MedTrace Logo

A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel

NCT01326013 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1534

Last updated 2012-08-24

No results posted yet for this study

Summary

The xTAG Gastrointestinal Pathogen Panel (xTAG GPP) is a PCR-based assay to detect the presence or absence of gastrointestinal (GI) pathogens from human stool specimens.

The objective of this study is to establish diagnostic accuracy of the xTAG GPP.

Conditions

Sponsors & Collaborators

  • Luminex Molecular Diagnostics

    lead INDUSTRY

Principal Investigators

  • Jeremy Liu, Ph.D · Luminex Molecular Diagnostics

  • Tony Mazzulli, M.D., F.R.C.P.(C), FACP · MOUNT SINAI HOSPITAL

  • Robert C. Fader, Ph.D · Scott and White Hospital & Clinic

  • James Mahony, Ph.D, FCCM, FAAM · St. Joseph's Hospital

  • Yi-Wei Tang, M.D., Ph.D · Vanderbilt University Medical Centre

  • Richard Buller, Ph.D., D(ABMM) · St. Louis Children's Hospital

  • Donna M. Wolk, Ph.D., D.(ABMM) · University of Arizona

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01326013 on ClinicalTrials.gov